Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603)?

× No keyword cloud information.

4 in total

1. Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.

Authors: Guosu Wang; Richard Franklin; Ying Hong; Jorge D Erusalimsky
Journal: Br J Pharmacol Date: 2005-10 Impact factor: 8.739

Review 2. The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia.

Authors: Gunnar Birgegård
Journal: Curr Hematol Malig Rep Date: 2016-10 Impact factor: 3.952

3. Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity.

Authors: Karima Ighilahriz-Boubchir; Baya Boutemeur-Kheddis; Cherifa Rabia; Malika Makhloufi-Chebli; Maamar Hamdi; Artur M S Silva
Journal: Molecules Date: 2017-12-21 Impact factor: 4.411

4. TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.

Authors: Jan Palmblad; Magnus Björkholm; Jack Kutti; Gerd Lärfars; Eva Löfvenberg; Berit Markevärn; Mats Merup; Nils Mauritzson; Jan Westin; Jan Samuelsson; Gunnar Birgegård
Journal: Int J Med Sci Date: 2008-04-13 Impact factor: 3.738

4 in total